On July 27, 2026, Westridge Laboratories — the Santa Ana, California company behind ID Lubricants — announced it had acquired Mayer Laboratories, the Berkeley-based manufacturer of Kimono condoms and Blossom Organics personal lubricants. The deal folds two of the sexual wellness category's older independent names into a single manufacturing and distribution platform, in what a Westridge representative described as a union bringing together "over 70 years of combined industry leadership."

Why It Matters

This is a quiet but instructive deal. Condoms and lubricants are the least glamorous corner of sexual wellness and also the most brutally competitive — a commodity-adjacent category dominated by a handful of giants (Church & Dwight's Trojan, Reckitt's Durex, Karex as the contract-manufacturing backbone) where independent brands survive on differentiation and distribution relationships rather than scale. Mayer built Kimono on the ultra-thin positioning and a reputation for advocacy; what it never had was manufacturing depth. The strategic read is that the barbell in this category is collapsing. Mid-size independents increasingly can't fund both brand-building and supply chain resilience at a moment when tariffs, latex sourcing, and counterfeit competition (see the EU's July bust of a 200,000-unit fake-condom network) all raise the cost of staying in the game. Rolling premium brand equity onto an owner with domestic manufacturing and distribution infrastructure is the rational answer — and it makes Westridge a considerably more serious full-service partner for the distributors, retailers, and public health organizations that buy in volume. Expect more of these tuck-ins: the sexual wellness consumables segment is fragmented enough that a determined roll-up strategy has plenty of runway.

The acquired portfolio is a genuine brand asset, not a shell. It includes the Kimono MicroThin line — a long-standing player in the ultra-thin latex condom niche — plus Kimono MAXX, Aqua Lube, and the Blossom Organics natural lubricant range. Per AVN's reporting, Westridge is also picking up Mayer's pipeline of recently developed products and formulas that it intends to bring to market. Founder David Mayer and his team will remain closely involved with the brands rather than exiting outright.

Westridge founder and president Gregg Haskell framed the logic in classic platform-consolidation terms: "Mayer Laboratories has built an extraordinary legacy defined by quality, advocacy, and a 'best in class' product philosophy. We aren't just acquiring brands; we are investing in a shared vision. By combining our manufacturing agility with Mayer's specialized product expertise, we are positioned to accelerate and expand the reach of these essential wellness brands." Mayer, for his part, said finding "a partner that shares our commitment to consumer education and product integrity was paramount," and that Westridge's "capacity and operational scale will provide the resources needed to thrive in a rapidly evolving global market."

Neither company disclosed financial terms.

Sources

Update — 2026-07-28

Initial entry — story first created.